PPARG and small cell lung carcinoma: Lastly, sulindac sulfide, belonging to another class of PPARγ ligands (nonsteroidal anti-inflammatory drugs), has also been shown to decrease anchorage-independent growth, a common measure of tumorigenicity, in both NSCLC and SCLC cells [38].